COVAXIN phase 3 trials will start soon: Bharat Biotech Executive Director
October 31, 2020
Bharat Biotech is soon going to start Phase-3 trials for ‘COVAXIN’ with an investment of Rs 150 crore that will include 26,000 participants. These trials will be conducted in 25 sites across India. Talking exclusively to The Daily Guardian, Sai Prasad, the Executive Director of Bharat Biotech International Ltd, spoke...
Read More